US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist
  • 25.190
  • -0.130-0.51%
Close Mar 28 16:00 ET
  • 25.190
  • 0.0000.00%
Post 17:12 ET
2.61BMarket Cap26.80P/E (TTM)

Corcept Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
20.04%482.38M
31.39%135.41M
21.50%123.6M
13.86%117.72M
12.77%105.65M
9.80%401.86M
4.28%103.06M
5.82%101.73M
12.88%103.39M
17.94%93.69M
Operating revenue
20.04%482.38M
31.39%135.41M
21.50%123.6M
13.86%117.72M
12.77%105.65M
9.80%401.86M
4.28%103.06M
5.82%101.73M
12.88%103.39M
17.94%93.69M
Cost of revenue
20.35%6.48M
26.82%1.88M
22.85%1.65M
19.60%1.57M
10.88%1.39M
1.97%5.39M
9.31%1.48M
5.02%1.34M
-4.91%1.32M
-1.42%1.25M
Gross profit
20.03%475.89M
31.46%133.53M
21.48%121.96M
13.79%116.14M
12.80%104.27M
9.92%396.47M
4.21%101.58M
5.83%100.39M
13.15%102.07M
18.25%92.44M
Operating expense
29.87%368.61M
28.81%101.86M
32.61%90.78M
22.54%86.56M
36.16%89.42M
20.16%283.84M
30.05%79.08M
16.77%68.46M
21.24%70.64M
12.20%65.67M
Selling and administrative expenses
20.55%184.26M
11.41%47.15M
28.72%45.26M
14.46%43.28M
29.34%48.56M
24.92%152.85M
31.09%42.32M
15.16%35.16M
25.92%37.81M
27.25%37.55M
Research and development costs
40.74%184.35M
48.85%54.71M
36.72%45.52M
31.84%43.28M
45.27%40.85M
15.04%130.99M
28.88%36.75M
18.51%33.29M
16.27%32.83M
-3.11%28.12M
Operating profit
-4.75%107.28M
40.76%31.67M
-2.37%31.18M
-5.88%29.58M
-44.51%14.85M
-9.51%112.63M
-38.63%22.5M
-11.86%31.93M
-1.60%31.43M
36.31%26.77M
Net non-operating interest income expense
385.66%17.28M
189.25%5.14M
386.73%5.21M
431.27%3.35M
4,376.25%3.58M
572.40%3.56M
2,368.06%1.78M
1,386.11%1.07M
472.73%630K
-70.91%80K
Non-operating interest income
385.66%17.28M
189.25%5.14M
386.73%5.21M
431.27%3.35M
4,376.25%3.58M
572.40%3.56M
2,368.06%1.78M
1,386.11%1.07M
472.73%630K
-70.91%80K
Other net income (expense)
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
Income before tax
7.20%124.56M
51.63%36.81M
10.24%36.39M
2.71%32.93M
-31.34%18.43M
-7.05%116.19M
-33.92%24.28M
-9.09%33M
0.03%32.06M
34.83%26.85M
Income tax
24.67%18.42M
-28.94%5.45M
412.16%5.01M
16.17%5.4M
-36.94%2.56M
18.24%14.77M
63.89%7.68M
-127.50%-1.6M
-15.91%4.65M
214.08%4.05M
Net income
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
13.58%34.61M
3.35%27.41M
-2.85%22.8M
Net income continuous Operations
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
13.58%34.61M
3.35%27.41M
-2.85%22.8M
Minority interest income
Net income attributable to the parent company
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
13.58%34.61M
3.35%27.41M
-2.85%22.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.15%105.5M
88.37%31.14M
-9.78%31.17M
-0.15%27.36M
-30.66%15.81M
-9.98%101.29M
-48.42%16.53M
13.39%34.55M
3.30%27.4M
-2.85%22.8M
Basic earnings per share
7.37%1.02
100.00%0.3
-3.13%0.31
3.85%0.27
-31.82%0.15
-2.06%0.95
-46.43%0.15
23.08%0.32
13.04%0.26
10.00%0.22
Diluted earnings per share
8.05%0.94
100.00%0.28
-6.67%0.28
4.17%0.25
-30.00%0.14
-2.25%0.87
-46.15%0.14
25.00%0.3
14.29%0.24
11.11%0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 20.04%482.38M31.39%135.41M21.50%123.6M13.86%117.72M12.77%105.65M9.80%401.86M4.28%103.06M5.82%101.73M12.88%103.39M17.94%93.69M
Operating revenue 20.04%482.38M31.39%135.41M21.50%123.6M13.86%117.72M12.77%105.65M9.80%401.86M4.28%103.06M5.82%101.73M12.88%103.39M17.94%93.69M
Cost of revenue 20.35%6.48M26.82%1.88M22.85%1.65M19.60%1.57M10.88%1.39M1.97%5.39M9.31%1.48M5.02%1.34M-4.91%1.32M-1.42%1.25M
Gross profit 20.03%475.89M31.46%133.53M21.48%121.96M13.79%116.14M12.80%104.27M9.92%396.47M4.21%101.58M5.83%100.39M13.15%102.07M18.25%92.44M
Operating expense 29.87%368.61M28.81%101.86M32.61%90.78M22.54%86.56M36.16%89.42M20.16%283.84M30.05%79.08M16.77%68.46M21.24%70.64M12.20%65.67M
Selling and administrative expenses 20.55%184.26M11.41%47.15M28.72%45.26M14.46%43.28M29.34%48.56M24.92%152.85M31.09%42.32M15.16%35.16M25.92%37.81M27.25%37.55M
Research and development costs 40.74%184.35M48.85%54.71M36.72%45.52M31.84%43.28M45.27%40.85M15.04%130.99M28.88%36.75M18.51%33.29M16.27%32.83M-3.11%28.12M
Operating profit -4.75%107.28M40.76%31.67M-2.37%31.18M-5.88%29.58M-44.51%14.85M-9.51%112.63M-38.63%22.5M-11.86%31.93M-1.60%31.43M36.31%26.77M
Net non-operating interest income expense 385.66%17.28M189.25%5.14M386.73%5.21M431.27%3.35M4,376.25%3.58M572.40%3.56M2,368.06%1.78M1,386.11%1.07M472.73%630K-70.91%80K
Non-operating interest income 385.66%17.28M189.25%5.14M386.73%5.21M431.27%3.35M4,376.25%3.58M572.40%3.56M2,368.06%1.78M1,386.11%1.07M472.73%630K-70.91%80K
Other net income (expense)
Special income (charges) --0------------------0----------------
Income before tax 7.20%124.56M51.63%36.81M10.24%36.39M2.71%32.93M-31.34%18.43M-7.05%116.19M-33.92%24.28M-9.09%33M0.03%32.06M34.83%26.85M
Income tax 24.67%18.42M-28.94%5.45M412.16%5.01M16.17%5.4M-36.94%2.56M18.24%14.77M63.89%7.68M-127.50%-1.6M-15.91%4.65M214.08%4.05M
Net income 4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M13.58%34.61M3.35%27.41M-2.85%22.8M
Net income continuous Operations 4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M13.58%34.61M3.35%27.41M-2.85%22.8M
Minority interest income
Net income attributable to the parent company 4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M13.58%34.61M3.35%27.41M-2.85%22.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.15%105.5M88.37%31.14M-9.78%31.17M-0.15%27.36M-30.66%15.81M-9.98%101.29M-48.42%16.53M13.39%34.55M3.30%27.4M-2.85%22.8M
Basic earnings per share 7.37%1.02100.00%0.3-3.13%0.313.85%0.27-31.82%0.15-2.06%0.95-46.43%0.1523.08%0.3213.04%0.2610.00%0.22
Diluted earnings per share 8.05%0.94100.00%0.28-6.67%0.284.17%0.25-30.00%0.14-2.25%0.87-46.15%0.1425.00%0.314.29%0.2411.11%0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg